Companies in Moscow, Russian Federation |
|
Short by: Alphabetic | Date |
|
|
| Doctor Web, Ltd. - a Russian company developing and distributing Dr.Web® anti-virus solutions, was founded by the author of Dr.Web anti-virus programs Igor Daniloff in December 2003 in order to centralize the development and distribution of the Dr.Web anti-viruses, provide for efficient technical support of the highest level for all our customers using Dr.Web for protection of their information systems. More... |
|
|
|
|
| FINAM Investment Holding is one of Russia's oldest and most venerable investment holdings. Since its inception in 1994, a time of rough-and-tumble capitalism when the secondary market was just coming to life, FINAM has gradually evolved into a mainstream one-stop brokerage offering the entire range of seamless equity solutions to domestic and foreign investors and established itself as a leading Moscow-based brokerage with regional offices spanning the entire country. At present, the holding comprises FINAM Investment Company (ranked among Russia’s top five investment companies), Finam.ru information agency, management company Finam Management, insurance broker Finam Insurance, bank Megawatt-Bank, the direct investment fund for hi-tech projects, MoneyMail payment system and a number of assets in various industries. More... |
|
|
|
|
| Aml Pages is a notes organizer More... |
|
|
|
|
| geology geophysics hydrodynamics geophysical research hydrodynamics research oil & gas wells oil & gas pool development well development More... |
|
|
|
|
| Software to convert MS Access, DBF and Oracle databases to MySQL and vice versa, PDF to Word, PDF to HTML, PDF to text and others More... |
|
|
|
|
| Quantum Pharmaceuticals develops and markets an original computational drug discovery platform. The core of the computer aided drug design technology is a reliable method to calculate protein-ligand binding affinity. Hit identification module of Quantum molecular modeling technology provides very high hit rate - from 10% to 50% depending on the complexity of the protein target. Quantum technology platform allows also to make reliable Pharmacokinetic and Toxicology predictions at the very early stage based on the molecular structure of compound only.
Quantum Pharmaceuticals has partnerships with leading chemical providers, which enable o work with libraries of several millions of deliverable or synthesizable compounds. Quantum Pharmaceuticals currently have projects in hit/lead identification and optimization with companies and organization around the world, including Top Pharma and Academia.
Quantum Pharmaceuticals is offering drug discovery collaborations on the basis of Quantum Pharmaceuticals’ inhibitors with predicted activity for the variety of therapeutic targets and proper predicted ADMET profile. The contract research services are also available.
The technology platform is applicable virtually in any therapeutic area. It had been already successfully implemented in antibacterial research (FtsZ target), antiviral (HIV-1 integrase), COPD (Human Neutrophil Elastase), oncology (IGFR and other kinases) and many others.
The technology is also applicable in discovery of novel bioactive chemical entities and toxicity research in many others areas, such as crop protection, environmental risk assessment, food supplements, cosmetics etc. More... |
|
|
[1] [2] [3] [4]
|
|
